| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.03 |